tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Butler, 206 are a BUY (94.93%), 10 are a HOLD (4.61%), 1 are a SELL (0.46%).
Analyst Jason Butler, currently employed at JMP, carries an average stock price target met ratio of 35.38% that have a potential upside of 50.39% achieved within 173 days.
Jason Butler’s has documented 435 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on AQST, Aquestive Therapeutics at 26-Jun-2024.
Analyst best performing recommendations are on TRVN (TREVENA).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS) at 2/24/2021. The price target of $48 was fulfilled within 1 day with a profit of $3.45 (6.71%) receiving and performance score of 67.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
28
$10.25 (57.75%)
30
14 days ago
16/20 (80%)
$10.23 (57.57%)
184
Buy
29
$11.25 (63.38%)
35
1 months 1 days ago
10/17 (58.82%)
$13.4 (85.90%)
235
Hold
22
$4.25 (23.94%)
30
2 months 16 days ago
6/7 (85.71%)
$6.75 (44.26%)
281
Buy
28
$10.25 (57.75%)
40
2 months 17 days ago
0/2 (0%)
$12.79 (84.09%)
Hold
21
$3.25 (18.31%)
27
2 months 17 days ago
13/17 (76.47%)
$5.79 (38.07%)
88
Which stock is Jason Butler is most bullish on?
Which stock is Jason Butler is most reserved on?
What Year was the first public recommendation made by Jason Butler?
